RNTTX
Price
$50.31
Change
+$0.38 (+0.76%)
Updated
Oct 13 closing price
Net Assets
1.09B
VDVIX
Price
$14.87
Change
+$0.17 (+1.16%)
Updated
Oct 13 closing price
Net Assets
250.77B
Interact to see
Advertisement

RNTTX vs VDVIX

Header iconRNTTX vs VDVIX Comparison
Open Charts RNTTX vs VDVIXBanner chart's image
Russell Inv International Devd Mkts M
Price$50.31
Change+$0.38 (+0.76%)
VolumeN/A
Net Assets1.09B
Vanguard Developed Markets Index I
Price$14.87
Change+$0.17 (+1.16%)
VolumeN/A
Net Assets250.77B
RNTTX vs VDVIX Comparison Chart in %
View a ticker or compare two or three
VS
RNTTX vs. VDVIX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNTTX is a StrongBuy and VDVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VDVIX has more cash in the bank: 251B vs. RNTTX (1.09B). RNTTX pays higher dividends than VDVIX: RNTTX (2.89) vs VDVIX (2.69). RNTTX was incepted earlier than VDVIX: RNTTX (9 years) vs VDVIX (12 years). RNTTX (1.03) is less costly to investors than VDVIX (0.16). RNTTX is a more actively managed with annual turnover of: 28.00 vs. VDVIX (3.00). RNTTX (0) and VDVIX (0) have matching initial minimum investment requirements. VDVIX annual gain was more profitable for investors over the last year : 14.36 vs. RNTTX (13.63). RNTTX return over 5 years is better than : 56.02 vs. VDVIX (44.39).
RNTTXVDVIXRNTTX / VDVIX
Total Expense Ratio0.870.16544%
Annual Report Gross Expense Ratio1.030.16644%
Fund Existence9 years12 years-
Gain YTD21.45523.92890%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B251B0%
Annual Yield % from dividends2.892.69107%
Returns for 1 year13.6314.3695%
Returns for 3 years69.1465.34106%
Returns for 5 years56.0244.39126%
Returns for 10 yearsN/A63.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATHE4.660.37
+8.62%
Alterity Therapeutics Limited
GTBP0.740.06
+8.47%
GT Biopharma
IMXI14.710.21
+1.45%
International Money Express
BBIO55.960.47
+0.85%
BridgeBio Pharma
ATEC13.240.10
+0.76%
Alphatec Holdings